Zymeworks (ZYME) Non-Current Deferred Tax Liability (2021 - 2026)

Zymeworks' (ZYME) quarterly Non-Current Deferred Tax Liability came in at $3.8 million in Q1 2026, down 20.52% year-on-year from $4.8 million in Q1 2025, and down 36.51% quarter-over-quarter from $6.0 million in Q4 2025.

Zymeworks (ZYME) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Non-Current Deferred Tax Liability across 6 years of filings, most recently posting $3.8 million for Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $3.8 million, down 20.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (down 20.52% YoY), and the FY2025 annual result was $6.0 million, up 26.61% from the prior year.
  • Non-Current Deferred Tax Liability came in at $3.8 million for Q1 2026 at Zymeworks, down from $6.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.0 million in Q4 2025 to a low of $1.6 million in Q3 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $3.4 million (2024), against an average of $3.4 million.
  • Across the five-year window, Non-Current Deferred Tax Liability plunged 87.32% in 2022 and jumped 84.56% in 2023, its largest moves.
  • Zymeworks' Non-Current Deferred Tax Liability stood at $1.8 million in 2022, then surged by 84.56% to $3.3 million in 2023, then soared by 44.27% to $4.8 million in 2024, then rose by 26.61% to $6.0 million in 2025, then slumped by 36.51% to $3.8 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $3.8 million (Q1 2026), $6.0 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Zymeworks 1.71 Bn 1.35 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.83 Mn
Mar 31, 2026 3.83 Mn
Dec 31, 2025 6.03 Mn
Dec 31, 2025 6.03 Mn
Sep 30, 2025 4.77 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 4.85 Mn
Jun 30, 2025 4.85 Mn
Mar 31, 2025 4.82 Mn
Mar 31, 2025 4.82 Mn
Dec 31, 2024 4.76 Mn
Dec 31, 2024 4.76 Mn
Sep 30, 2024 3.46 Mn
Sep 30, 2024 3.46 Mn
Jun 30, 2024 3.40 Mn
Jun 30, 2024 3.40 Mn
Mar 31, 2024 3.35 Mn
Mar 31, 2024 3.35 Mn
Dec 31, 2023 3.30 Mn
Dec 31, 2023 3.30 Mn